ライフサイエンスコーパス: insulin injection

1 rylation of Akt and FoxO1 following systemic insulin injection.

2 re of blood glucose levels to decrease after insulin injection.

3 ose fell to <60 mg/dl after a jugular venous insulin injection.

4 ency which developed between 5 and 8 h after insulin injection.

5 l mice) and abnormal glucose clearance after insulin injection.

6 sulin plus a bedtime subcutaneous ultralente insulin injection.

7 n pump therapy or with multiple (>/=4) daily insulin injections.

8 type 1 diabetes treated with multiple daily insulin injections.

9 ubled with placebo and further elevated with insulin injections.

10 sive alternative to conventional preprandial insulin injections.

11 n be extended, thereby delaying the need for insulin injections.

12 in adults with type 1 diabetes treated with insulin injections.

13 ients treated with conventional subcutaneous insulin injections.

14 5% (58 mmol/mol) treated with multiple daily insulin injections.

15 Type I diabetics are dependent on daily insulin injections.

16 s within 2% of that observed with peripheral insulin injection (1,820 +/- 711 vs. 1,791 +/- 661 micro

17 tu contraction, and 15 min following maximal insulin injection (16.6 units/kg of body weight).

18 its exogenous tyrosine kinase activity after insulin injection (64%; p < 0.01 and 96% and p < 0.001,

19 -stage T2DM conditions that require repeated insulin injection and can potentially minimize the occur

20 e, time course experiments on the effects of insulin injection and treadmill running exercise were pe

21 millions of patients have relied on frequent insulin injections and glucose monitoring to combat the

22 ype 1 diabetes who were using multiple daily insulin injections and had hemoglobin A1c (HbA1c) levels

23 afish recovered rapidly without the need for insulin injections, and normoglycemia was attained withi

24 reated diabetic subjects used multiple daily insulin injections; and 40% of patients with insulin-dep

25 diabetic rats were treated with twice-daily insulin injections, basal hepatic insulin production, or

26 or-bound insulin in endosomes at 2 min after insulin injection by 93% as determined by exclusion from

27 tatrophin treatment could augment or replace insulin injections by increasing the number of endogenou

28 Insulin injection caused a similar reduction of circulat

29 Unlike the saline group, each incremental insulin injection caused interstitial (lymph) insulin to

30 abetes mellitus usually requires two or more insulin injections daily.

31 Standard insulin therapy was one or two insulin injections daily.

32 and undesirable side-effects associated with insulin injection demand novel drugs for the diseases.

33 rvet monkeys receiving twice-daily exogenous insulin injections for 8-20 weeks.

34 lt, acutely diabetic NOD mice do not require insulin injections for survival for a significant time p

35 entage of adults who received multiple daily insulin injections for type 2 diabetes used CGM on a dai

36 iving no insulin injections, those receiving insulin injections had a dose-response increase in the o

37 control of hypoglycemic seizures induced by insulin injection in fasted and nonfasted rats.

38 on has led to sulfonylurea therapy replacing insulin injections in many patients.

39 orphic PDK1 mice are viable and fertile, and insulin injection induces the normal activation of PKB,

40 py) with that of a regimen of multiple daily insulin injections (injection therapy) in 485 patients (

41 insulin receptor content of endosomes after insulin injection (integrated over 0-45 min) by 31% when

42 ted to the loss of the anorectic response to insulin injections into the central nucleus of the amygd

43 regimen for type 1 diabetes with twice-daily insulin injections is effective in preventing postprandi

44 (Rx) of either IP (n = 9) or multiple daily insulin injections (MDI; n = 13).

45 (median duration, 3.7 years) and 16460 used insulin injections (median duration, 3.6 years).

46 e obtained from mice 10, 15, or 30 min after insulin injection or immediately after strenuous treadmi

47 Despite daily insulin injections, patients typically develop cardiovas

48 The mean number of insulin injections per day increased from 2.2 to 2.5 acr

49 Insulin injection resulted in normal tyrosyl phosphoryla

50 Strikingly, a single insulin injection reversed the deleterious effects of HF

51 However, we found that daily insulin injections significantly increased weight gain i

52 dministration requires frequent subcutaneous insulin injections that are associated with poor patient

53 ally accurate when it was assumed that after insulin injection the glycemia in the subcutaneous fluid

54 te of decline exceeded 1.8 mg/(dl.min) after insulin injection, the subcutaneous glucose concentratio

55 with type 1 diabetes who used multiple daily insulin injections, the use of CGM compared with usual c

56 type 1 diabetes treated with multiple daily insulin injections, the use of continuous glucose monito

57 ely move type 1 diabetes treatment away from insulin injection therapy and toward a cure.

58 ower with insulin pump therapy compared with insulin injection therapy in children, adolescents, and

59 iabetes, insulin pump therapy, compared with insulin injection therapy, was associated with lower ris

60 red with patients with diabetes receiving no insulin injections, those receiving insulin injections h

61 concentration between 6 and 20 min after the insulin injection was different for subcutaneous tissue

62 ea under the insulin curves after the portal insulin injection was within 2% of that observed with pe

63 et of experiments, a control "zero" dose (no insulin injection) was also performed.

64 Daily insulin injections were given to four groups of rats and